Table 1. Age at Blood Draw and First Serum PSA Level for Men in Jönköping Region, Sweden, 2016-2020.
Characteristic | Participants, No. (%) | |||||
---|---|---|---|---|---|---|
2016 (n = 6330)a | 2017 (n = 5161) | 2018 (n = 5286) | 2019 (n = 4910) | 2020 (n = 2111)a | 2016-2020 (n = 23 802) | |
Age range, y | ||||||
≤35 | 193 (3.0) | 178 (3.4) | 191 (3.6) | 196 (4.0) | 107 (5.1) | 866 (3.6) |
36-45 | 563 (8.9) | 456 (8.8) | 457 (8.6) | 468 (9.5) | 190 (9.0) | 2134 (9.0) |
46-50 | 714 (11.3) | 603 (11.7) | 560 (10.6) | 518 (10.5) | 235 (11.1) | 2630 (11.0) |
51-55 | 815 (12.9) | 706 (13.7) | 778 (14.7) | 664 (13.5) | 338 (16.0) | 3301 (13.9) |
56-60 | 882 (13.9) | 719 (13.9) | 694 (13.1) | 662 (13.5) | 274 (13.0) | 3232 (13.6) |
61-65 | 874 (13.8) | 695 (13.5) | 716 (13.5) | 629 (12.8) | 260 (12.3) | 3174 (13.3) |
66-70 | 867 (13.7) | 643 (12.5) | 639 (12.1) | 580 (11.8) | 220 (10.4) | 2949 (12.4) |
71-75 | 581 (9.2) | 493 (9.6) | 552 (10.4) | 479 (9.8) | 196 (9.3) | 2301 (9.7) |
76-80 | 386 (6.1) | 283 (5.5) | 365 (6.9) | 346 (7.0) | 148 (7.0) | 1530 (6.4) |
81-85 | 269 (4.2) | 220 (4.3) | 186 (3.5) | 209 (4.3) | 78 (3.7) | 962 (4.0) |
≥86 | 186 (2.9) | 165 (3.2) | 148 (2.8) | 159 (3.2) | 65 (3.1) | 723 (3.0) |
PSA level, ng/mL | ||||||
0 to <3 | 4976 (78.6) | 4099 (79.4) | 4327 (81.9) | 4053 (82.5) | 1704 (80.7) | 19163 (80.5) |
3 to <10 | 1026 (16.2) | 801 (15.5) | 729 (13.8) | 634 (12.9) | 303 (14.4) | 3493 (14.7) |
10 to <20 | 185 (2.9) | 136 (2.6) | 125 (2.4) | 118 (2.4) | 48 (2.3) | 612 (2.6) |
20 to <100 | 102 (1.6) | 94 (1.8) | 84 (1.6) | 77 (1.6) | 39 (1.8) | 396 (1.7) |
≥100 | 41 (0.6) | 31 (0.6) | 21 (0.4) | 28 (0.6) | 17 (0.8) | 138 (0.6) |
Abbreviation: PSA, prostate-specific antigen.
SI conversion factor: To convert PSA to micrograms per liter, multiply by 1.
Data for 2016 correspond to PSA test performed from November 1, 2015, to December 31, 2016. Data for 2020 correspond to tests performed from January 1, 2020, to July 31, 2020.